Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.

After decades of slow progress in understanding and developing effective treatments for Alzheimer’s disease, scientists are ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

The NHS will reconsider approving two Alzheimer’s “wonder drugs” after a successful appeal. The National Institute of Health ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears to slow memory loss, giving patients the gift of more time. UW Medicine's ...

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss?

Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive function and quality of life.

A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...

Research roundtable highlights early detection, biomarkers, interventions ...

The Alzheimer's Drug Discovery Foundation (ADDF) today announced that Isobel Coleman has been named Chief Executive Officer, ...

Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new ...